XBiotech (XBIT) Financial Statements

XBiotech's market cap is currently $65.85M. The company's EPS TTM is $-1.264; its P/E ratio is -2.34; XBiotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.